Brief: Orchard Therapeutics And Molmed Announce Extension Of Gene Therapy Manufacturing Collaboration
09/07/2020 12:50
July 9 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS AND MOLMED ANNOUNCE EXTENSION OF GENE
THERAPY MANUFACTURING COLLABORATION
* ORCHARD THERAPEUTICS - CO, MOLMED S.P.A HAVE EXTENDED
THEIR
COLLABORATION - INITIATED IN APRIL 2018 FOR PERIOD OF FIVE YEARS
THROUGH JUNE 2025
* ORCHARD THERAPEUTICS PLC - OTL-200 FOR MLD IS CURRENTLY
UNDER
REVIEW BY EMA WITH A DECISION EXPECTED LATER THIS YEAR
Source text for Eikon: ID:nGNX7hyNCk
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln